Health system leaders reflect on the impact of EHRs 15 years after meaningful use incentives, citing improved patient access and safety but also challenges.
Peregrine Capital Management LLC lowered its position in shares of Coherus BioSciences, Inc. (NASDAQ:CHRS – Free Report) by 20.9% in the fourth quarter, according to the company in its most recent filing with the SEC. The firm owned 1,089,961 shares of the biotechnology company’s stock after selling 288,606 shares during the quarter. Peregrine Capital Management […]
Peregrine Capital Management LLC trimmed its stake in shares of Coherus BioSciences, Inc. (NASDAQ:CHRS – Free Report) by 20.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,089,961 shares of the biotechnology company’s stock after selling 288,606 shares […]